BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 358597)

  • 1. [Dynamics of secretory and serum immunoglobulins in children in the course of vaccinations with live poliomyelitis monovaccines].
    Shmel'kov IuA; Zhevandrova VI; Drozdov SG
    Vopr Virusol; 1978; (3):332-6. PubMed ID: 358597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins level in saliva of children with poliomyelitis and of healthy children after oral vaccination with live attenuated poliovirus strains type 2 and 3.
    Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
    Pol Med J; 1970; 9(5):1168-72. PubMed ID: 4101723
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Change in the level of immunoglobulins A in the intestines of children after administration of live trivalent poliomyelitis vaccine by different methods].
    Shmel'kov IuA
    Vopr Virusol; 1978; (4):434-8. PubMed ID: 219616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoglobulin level in the saliva of children with poliomyelitis and healthy children following oral vaccination with live attenuatea strain of type 2 and 3 poliovirus].
    Szczepski O; Wlodarczak K; Walczak M; Walter Z; Klauziński R
    Pol Tyg Lek; 1970 Feb; 25(8):281-3. PubMed ID: 5417312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].
    Drozdov SG; Zhevandrova VI; Smirnova GA; Shmel'kov IuA; Kodkind GKh
    Vopr Virusol; 1979; (3):252-9. PubMed ID: 223328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS; Nossik NN; Bindu ; Vijayan P; Raghavan NG; Paul SS
    Bull World Health Organ; 1973; 48(2):195-8. PubMed ID: 4352611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of various methods of administration of live poliovirus vaccine on the immunoglobulin levels in the blood serum and mouth mucosa secretion in children].
    Shmel'kov IuA; Zhevandrova VI; Kodkind GKh; Drozdov SG; Alpatova GA
    Vopr Virusol; 1978; (1):89-94. PubMed ID: 645061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of immunization of seronegative children with live poliomyelitis vaccine].
    Babaev AA
    Vopr Virusol; 1978; (5):553-6. PubMed ID: 153652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
    Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
    J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins and immunity to poliomyelitis.
    Lancet; 1971 Apr; 1(7703):788. PubMed ID: 4101281
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization against poliomyelitis.
    Beale AJ
    Br Med Bull; 1969 May; 25(2):148-52. PubMed ID: 4319086
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of normal human immunoglobulins on the effectiveness of poliomyelitis vaccinations].
    Cotor F; Ivan A; Avram G; Radu M; Zavåte O
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(1):81-5. PubMed ID: 6156482
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific antibodies to poliovirus type I in breastmilk of unvaccinated mothers before and seven years after start of community-wide vaccination of their infants with live, oral poliovirus vaccine.
    Zaman S; Carlsson B; Jalil F; Jeansson S; Mellander L; Hanson LA
    Acta Paediatr Scand; 1991 Dec; 80(12):1174-82. PubMed ID: 1785290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Wiebe RA
    JAMA; 1978 May; 239(21):2252-5. PubMed ID: 206735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.